Mediget Teshome

Title(s)Associate Professor Of Clinical, Surgery
SchoolMedicine
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Mediget Teshome holds the Revlon Chair in Women's Health.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Medicaid Coverage of NCCN- and ASCO/SSO-Guideline-Concordant BRCA Germline Testing for Patients with Breast Cancer: Opportunity to Embrace Rapid Advancements in Precision Medicine. Ann Surg Oncol. 2024 Nov 23. Huston-Paterson HH, Mora V, Karlan BY, Teshome M. PMID: 39580377.
      View in: PubMed   Mentions:    Fields:    
    2. Setting the Standard for the Future of Cancer Surgery: Utilizing the Operative Standards for Trainees. J Surg Educ. 2024 Nov 23; 82(1):103345. Horowitz M, Sample J, Rudasill S, Zaveri S, Francescatti A, Teshome M, Villano A, Hieken T, Katz M, Hunt K. PMID: 39581164.
      View in: PubMed   Mentions:    Fields:    
    3. ASO Visual Abstract: Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2024 Nov 19. So A, Yi M, Simons JM, Kuerer HM, Caudle A, DeSnyder SM, Bedrosian I, Nead KT, Chavez-MacGregor M, Teshome M, Hunt KK. PMID: 39562423.
      View in: PubMed   Mentions:    Fields:    
    4. ASO Visual Abstract: Clinical Outcomes for Early-Stage Node-Negative HER2-Positive Breast Cancer Patients Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2024 Nov 19. Muppidi N, Adesoye T, Yi M, Sun SX, Chavez-MacGregor M, Singh P, Karuturi M, Tamirisa N, Hunt KK, Teshome M. PMID: 39562422.
      View in: PubMed   Mentions:    Fields:    
    5. Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial. Int J Radiat Oncol Biol Phys. 2024 Oct 30. Reddy JP, Sherry AD, Fellman B, Liu S, Bathala T, Haymaker C, Cohen L, Smith BD, Ramirez D, Shaitelman SF, Chun SG, Medina-Rosales M, Teshome M, Brewster A, Barcenas CH, Reuben A, Ghia AJ, Ludmir EB, Weed D, Shah SJ, Mitchell MP, Woodward WA, Gomez DR, Tang C. PMID: 39486645.
      View in: PubMed   Mentions:    Fields:    
    6. Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2024 Oct 23. So A, Yi M, Simons JM, Kuerer HM, Caudle A, DeSnyder SM, Bedrosian I, Nead KT, Chavez-MacGregor M, Teshome M, Hunt KK. PMID: 39441324.
      View in: PubMed   Mentions:    Fields:    
    7. ASO Visual Abstract: Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Ann Surg Oncol. 2024 Oct 23. Moore AM, Caudle AS, Sun SX, Yi M, Smith BD, Valero V, Yang W, Kuerer HM, Hunt KK, Teshome M. PMID: 39443343.
      View in: PubMed   Mentions:    Fields:    
    8. Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Ann Surg Oncol. 2024 Oct 17. Moore AM, Caudle AS, Sun SX, Yi M, Smith BD, Valero V, Yang W, Kuerer HM, Hunt KK, Teshome M. PMID: 39419889.
      View in: PubMed   Mentions:    Fields:    
    9. ASO Author Reflections: Evolving Multidisciplinary Decision Making for Early-Stage, HER2-Positive Breast Cancer. Ann Surg Oncol. 2024 Sep 09. Muppidi N, Adesoye T, Hunt KK, Teshome M. PMID: 39251515.
      View in: PubMed   Mentions:    Fields:    
    10. Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2024 Dec; 31(13):8795-8801. Muppidi N, Adesoye T, Yi M, Sun SX, Chavez-MacGregor M, Singh P, Karuturi M, Tamirisa N, Hunt KK, Teshome M. PMID: 39192013.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. 25nd Annual Meeting of the American Society of Breast Surgeons: Our Silver Jubilee. Ann Surg Oncol. 2024 Oct; 31(11):7245-7246. Gass J, Teshome M, Blair SL. PMID: 39164603.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Assessing Surgeon Familiarity with the Commission on Cancer Operative Standards for Cancer Surgery. Ann Surg Oncol. 2024 Oct; 31(10):6378-6386. Zaveri S, Teshome M, Reyna C, Francescatti AB, Yi M, Katz MHG, Hunt KK, Vreeland T. PMID: 39090487.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. ASO Author Reflections: The Path to Standardizing Surgical Cancer Care in the USA. Ann Surg Oncol. 2024 Oct; 31(10):6406-6407. Zaveri S, Teshome M, Katz MHG, Hunt KK, Vreeland T. PMID: 39090490.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 Oct; 31(11):7339-7346. Wanis KN, Goetz L, So A, Glencer AC, Sun SX, Teshome M, Resetkova E, Hwang RF, Hunt KK, Candelaria RP, Huo L, Singh P. PMID: 39048903.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection. Ann Surg Oncol. 2024 Oct; 31(11):7264-7270. Moore AM, Caudle AS, Sun SX, Yi M, Smith BD, Valero V, Yang W, Kuerer HM, Hunt KK, Teshome M. PMID: 39044106.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities. Ann Surg Oncol. 2024 Oct; 31(11):7326-7334. Glencer AC, Wanis KN, Brown S, Lucci A, Sun SX, Adesoye T, DeSnyder SM, Layman R, Woodward WA, Hunt KK, Teshome M. PMID: 39034365.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. ASO Author Reflections: Management of Inflammatory Breast Cancer: No Role for Surgical De-escalation Yet. Ann Surg Oncol. 2024 Oct; 31(11):7335-7336. Glencer AC, Hunt KK, Teshome M. PMID: 39020114.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Correction: Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6. Ann Surg Oncol. 2024 Jul; 31(7):4565. Thomas KK, Francescatti AB, Vreeland TJ, Teshome MK, Morris AM, Hunt KK, Katz MHG, Villano AM. PMID: 38662097.
      View in: PubMed   Mentions:    Fields:    
    19. Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation. JAMA Netw Open. 2024 Jun 03; 7(6):e2418486. Wanis KN, Kuerer HM, Sun SX, Hunt KK, Glencer AC, Teshome M, Lucci A, Weiser R, Johnson H, Smith BD, Gutierrez AM, Shaitelman SF, Arun BK. PMID: 38916888; PMCID: PMC11200147.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 May; 31(5):3196-3197. Cortina CS, Rogers CC, Teshome M. PMID: 38341380; PMCID: PMC11003827.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery? Ann Surg Oncol. 2024 May; 31(5):3128-3140. Cortina CS, Lloren JI, Rogers C, Johnson MK, Cobb AN, Huang CC, Kong AL, Singh P, Teshome M. PMID: 38270828; PMCID: PMC11003830.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer. Breast Cancer Res Treat. 2024 Apr; 204(2):289-297. Nakhlis F, Niman SM, Ueno NT, Troll E, Ryan S, Yeh E, Warren L, Bellon J, Harrison B, Iwase T, Carisa Le-Petross HT, Saleem S, Teshome M, Whitman GJ, Woodward WA, Overmoyer B, Tolaney SM, Regan M, Lynce F, Layman RM. PMID: 38155272.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management. Ann Surg Oncol. 2024 Apr; 31(4):2224-2230. Everidge SA, Sun J, Teshome M, Tamirisa N, Sun S, Adesoye T, Nia E, Bevers T, Bedrosian I, Patel M, Singh P. PMID: 38117388.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 Feb; 31(2):974-980. Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt KK, Meric-Bernstam F, Schaverien M, Barcenas CH, Sun SX. PMID: 37973647.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6. Ann Surg Oncol. 2024 Jan; 31(1):6-9. Thomas KK, Francescatti AB, Vreeland TJ, Teshome MK, Morris AM, Hunt KK, Katz MHG, Villano AM. PMID: 37880516.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement. J Am Coll Surg. 2024 01 01; 238(1):1-9. Sun SX, Piotrowski MJ, Adesoye T, Mitchell MP, Garber HR, Teshome M, Kuerer HM, Tamirisa N, Singh P. PMID: 37870227.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial. Breast Cancer Res Treat. 2024 Jan; 203(2):317-328. Rogers C, Cobb AN, Lloren JIC, Chaudhary LN, Johnson MK, Huang CC, Teshome M, Kong AL, Singh P, Cortina CS. PMID: 37864105; PMCID: PMC10872271.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer? Ann Surg Oncol. 2023 Dec; 30(13):8327-8334. Farley C, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, Hunt K, Kuerer H, Singh P, Sun S, Tamirisa N, Teshome M, Hwang RF. PMID: 37670121.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. 24th Annual Meeting of the American Society of Breast Surgeons (ASBRS): One If by Land, Two If by Sea: ASBRS Rides Into Boston. Ann Surg Oncol. 2023 10; 30(10):5945-5946. Brigid KB, Teshome M, Blair SL. PMID: 37598117.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma. Eur J Cancer. 2023 09; 191:113250. Mouabbi JA, Raghavendra AS, Bassett RL, Christgen M, Middleton L, Teshome M, Nasrazadani A, Hortobagyi G, Hassan A, Tripathy D, Layman RM. PMID: 37573674; PMCID: PMC10529602.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy. Ann Surg Oncol. 2023 Oct; 30(10):6232-6240. Adesoye T, Everidge S, Chen J, Sun SX, Teshome M, Valero V, Woodward WA, Lucci A. PMID: 37479842.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection. Ann Surg Oncol. 2023 Nov; 30(12):7015-7025. Zaveri S, Everidge S, FitzSullivan E, Hwang R, Smith BD, Lin H, Shen Y, Lucci A, Teshome M, Sun SX, Hunt KK, Kuerer HM. PMID: 37458948.
      View in: PubMed   Mentions: 1     Fields:    
    33. Lactation Education for Surgeons: American Society of Breast Surgeons (ASBrS) Survey Demonstrates Strong Member Interest in Expanded Training. Ann Surg Oncol. 2023 Oct; 30(10):6125-6132. Johnson HM, Teshome M, Singh P, Mitchell KB. PMID: 37452168.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. A spatially resolved single-cell genomic atlas of the adult human breast. Nature. 2023 Aug; 620(7972):181-191. Kumar T, Nee K, Wei R, He S, Nguyen QH, Bai S, Blake K, Pein M, Gong Y, Sei E, Hu M, Casasent AK, Thennavan A, Li J, Tran T, Chen K, Nilges B, Kashikar N, Braubach O, Ben Cheikh B, Nikulina N, Chen H, Teshome M, Menegaz B, Javaid H, Nagi C, Montalvan J, Lev T, Mallya S, Tifrea DF, Edwards R, Lin E, Parajuli R, Hanson S, Winocour S, Thompson A, Lim B, Lawson DA, Kessenbrock K, Navin N. PMID: 37380767; PMCID: PMC11443819.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    35. Operative standards for sentinel lymph node biopsy and axillary lymphadenectomy for breast cancer: review of the American College of Surgeons commission on cancer standards 5.3 and 5.4. Surgery. 2023 09; 174(3):717-721. Zaveri S, Lillemoe HA, Teshome M, Reyna CR, Vreeland TJ, Francescatti AB, Zheng L, Hunt KK, Katz MHG, Kilgore LJ. PMID: 37202308.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. A spatially resolved single cell genomic atlas of the adult human breast. bioRxiv. 2023 Apr 25. Kumar T, Nee K, Wei R, He S, Nguyen QH, Bai S, Blake K, Gong Y, Pein M, Sei E, Hu M, Casasent A, Thennavan A, Li J, Tran T, Chen K, Nilges B, Kashikar N, Braubach O, Cheikh BB, Nikulina N, Chen H, Teshome M, Menegaz B, Javaid H, Nagi C, Montalvan J, Tifrea DF, Edwards R, Lin E, Parajuli R, Winocour S, Thompson A, Lim B, Lawson DA, Kessenbrock K, Navin N. PMID: 37163043; PMCID: PMC10168262.
      View in: PubMed   Mentions:
    37. Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy. Invest New Drugs. 2023 Jun; 41(3):391-401. Abuhadra N, Sun R, Bassett RL, Huo L, Chang JT, Teshome M, Clayborn AR, White JB, Ravenberg EE, Adrada BE, Candelaria RP, Yang W, Ding Q, Symmans WF, Arun B, Damodaran S, Koenig KB, Layman RM, Lim B, Litton JK, Thompson A, Ueno NT, Piwnica-Worms H, Hortobagyi GN, Valero V, Tripathy D, Rauch GM, Moulder S, Yam C. PMID: 37043123.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    38. Inflammatory Breast Cancer: Understanding the Patient Experience. Cancer Nurs. 2024 Jan-Feb 01; 47(1):E65-E72. Whisenant MS, Alexander A, Woodward WA, Teshome M, Ueno NT, Williams LA. PMID: 36729801.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Setting the Standard for Cutaneous Melanoma Wide Local Excision: An Overview of the American College of Surgeons Commission on Cancer Standard 5.5. J Am Coll Surg. 2023 02 01; 236(2):424-428. Lillemoe HA, Williams JK, Teshome MK, Zheng L, Francescatti AB, Hieken TJ, Katz MH, Hunt KH, Vreeland TJ, Asare EA. PMID: 36648270.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. 23rd Annual Meeting of the American Society of Breast Surgeons: Back to In-Person Scientific Exploration. Ann Surg Oncol. 2022 10; 29(10):6087-6089. Fisher CS, Teshome M, Blair SL. PMID: 35902494; PMCID: PMC9333076.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Ann Surg Oncol. 2022 Oct; 29(10):6370-6378. Farley CR, Irwin S, Adesoye T, Sun SX, DeSnyder SM, Lucci A, Shaitelman SF, Chang EI, Ueno NT, Woodward WA, Teshome M. PMID: 35854031.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    42. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol. 2022 Oct; 29(10):6381-6392. Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. PMID: 35834145.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. American College of Surgeons Commission on Cancer Standard 5.7 for Total Mesorectal Excision for Mid-to-Low Rectal Cancer. J Am Coll Surg. 2022 06 01; 234(6):1249-1253. Adams AM, Vreeland TJ, Teshome M, Francescatti AB, Zheng L, Hunt KK, Katz MHG, Messick CA. PMID: 35703824.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Progress and Persistent Challenges in Improving Care for Low-Income Women with Breast Cancer. Ann Surg Oncol. 2022 05; 29(5):2756-2758. Cobb AN, Adesoye T, Teshome M. PMID: 35152360; PMCID: PMC8853375.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Contemporary surgical management of inflammatory breast cancer: a narrative review. Chin Clin Oncol. 2021 Dec; 10(6):57. Adesoye T, Irwin S, Sun SX, Lucci A, Teshome M. PMID: 35016511.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    46. Impact of the early COVID-19 pandemic on Breast Surgical Oncology fellow education. J Surg Oncol. 2021 Dec; 124(7):989-994. Kilgore LJ, Murphy BL, Postlewait LM, Liang DH, Bedrosian I, Lucci A, Kuerer HM, Hunt KK, Teshome M. PMID: 34328640; PMCID: PMC8426719.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    47. Inflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol. 2021 Oct; 28(10):5626-5634. Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, Ueno NT, Hunt KK, Lucci A, Teshome M. PMID: 34292426.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    48. Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2021 Oct; 28(10):5477-5485. Elmore LC, Kuerer HM, Barcenas CH, Smith BD, Miggins MV, Lucci A, Caudle AS, Meric-Bernstam F, Hunt KK, Teshome M. PMID: 34247335.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    49. Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. 2021 Dec; 28(13):8610-8621. Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. PMID: 34125346.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    50. American College of Surgeons Commission on Cancer Standard for Curative-intent Pulmonary Resection. Ann Thorac Surg. 2022 01; 113(1):5-8. Nissen AP, Vreeland TJ, Teshome M, Archer MA, Francescatti AB, Katz MHG, Hunt KK, Zheng L, Mullett TW. PMID: 34119494.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    51. Unforeseen Collateral Damage of COVID-19 With the Virtualization of Fellowship Interviews. Ann Surg. 2021 06 01; 273(6):e271-e272. Rojas KE, Teshome M, Tevis SE. PMID: 33914481; PMCID: PMC8132558.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    52. The Devastating Legacy of Breast Cancer Death in Sub-Saharan Africa-Maternal Orphans and a Cycle of Disadvantage. JAMA Oncol. 2021 02 01; 7(2):197-198. Teshome M, Chavez-MacGregor M. PMID: 33355608.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol. 2021 Aug; 28(8):4265-4274. Partain N, Postlewait LM, Teshome M, Rosso K, Hall C, Song J, Meas S, DeSnyder SM, Lim B, Valero V, Woodward W, Ueno NT, Kuerer H, Lucci A. PMID: 33403525.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    54. Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):979. Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK. PMID: 32514803.
      View in: PubMed   Mentions:    Fields:    
    55. Male Mammary Paget Disease: A Tale of 2 Contrasting Cases. Am J Dermatopathol. 2020 Dec; 42(12):981-985. Roy M, Teshome M, Damodaran S, Sahin AA, Khazai L, Arribas E, Candelaria RP, Scoggins ME, Lane DL, Giordano SH, Albarracin CT, Prieto VG, Nagarajan P. PMID: 33289978.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial. Ann Surg Open. 2020 Dec; 1(2). Singh P, Scoggins ME, Sahin AA, Hwang RF, Kuerer HM, Caudle AS, Mittendorf EA, Thompson AM, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt KK. PMID: 34017965; PMCID: PMC8130552.
      View in: PubMed   Mentions: 5  
    57. Financial Toxicity Following Surgical Treatment for Breast Cancer: A Cross-sectional Pilot Study. Ann Surg Oncol. 2021 May; 28(5):2451-2462. Offodile AC, Asaad M, Boukovalas S, Bailey C, Lin YL, Teshome M, Greenup RA, Butler C. PMID: 33051742.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    58. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg. 2020 08; 272(2):e106-e111. Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. PMID: 32675511; PMCID: PMC7373457.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsPHPublic Health
    59. Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery? Ann Surg Oncol. 2020 Nov; 27(12):4603-4612. Postlewait LM, Teshome M, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Woodward WA, Ueno NT, Lucci A. PMID: 32710271.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    60. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol. 2020 Sep; 34:182-185. Tzeng CD, Tran Cao HS, Roland CL, Teshome M, Bednarski BK, Ikoma N, Graham PH, Keung EZ, Scally CP, Katz MHG, Gershenwald JE, Lee JE, Vauthey JN. PMID: 32891326; PMCID: PMC7187856.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsPHPublic Health
    61. Clinical trials-Designing, implementing, and collaborating. J Surg Oncol. 2020 Jul; 122(1):25-28. Roland CL, Grubbs EG, Katz MHG, Teshome M, Hunt KK, Tzeng CW. PMID: 32149390; PMCID: PMC7598771.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. An inflammatory imposter: Three cases of Mullerian carcinoma appearing as inflammatory breast cancer. Breast J. 2020 05; 26(5):1022-1024. Grant SR, Krishnamurthy S, Le-Petross C, Valero V, Teshome M, Woodward WA. PMID: 31960546.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors. Ann Surg Oncol. 2020 Apr; 27(4):1013-1022. Smith BD, Lei X, Diao K, Xu Y, Shen Y, Smith GL, Giordano SH, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Swanick CW. PMID: 31916092; PMCID: PMC7061073.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    64. Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2019 Oct; 26(10):3071-3079. Sun S, van la Parra RFD, Rauch GM, Checka C, Tadros AB, Lucci A, Teshome M, Black D, Hwang RF, Smith BD, Krishnamurthy S, Valero V, Yang WT, Kuerer HM. PMID: 31342361.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    65. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3510-3516. Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK. PMID: 31297674.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    66. Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach. Pract Radiat Oncol. 2019 Nov; 9(6):402-409. Stecklein SR, Rosso KJ, Nuanjing J, Tadros AB, Weiss A, DeSnyder SM, Kuerer HM, Teshome M, Buchholz TA, Stauder MC, Ueno NT, Lucci A, Woodward WA. PMID: 31132433.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients. Ann Surg Oncol. 2019 Mar; 26(3):815-820. Tevis SE, Bassett R, Bedrosian I, Barcenas CH, Black DM, Caudle AS, DeSnyder SM, Fitzsullivan E, Hunt KK, Kuerer HM, Lucci A, Meric-Bernstam F, Mittendorf EA, Park K, Teshome M, Thompson AM, Hwang RF. PMID: 30556120.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    68. Role of Operative Management in Stage IV Breast Cancer. Surg Clin North Am. 2018 Aug; 98(4):859-868. Teshome M. PMID: 30005779.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    69. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg. 2018 05; 267(5):946-951. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT. PMID: 28549010; PMCID: PMC6051523.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCTClinical Trials
    70. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer. 2018; 9(8):1437-1447. Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. PMID: 29721054; PMCID: PMC5929089.
      View in: PubMed   Mentions: 41  
    71. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg. 2017 07 01; 152(7):665-670. Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, Black DM, Lucci A, Caudle AS, DeSnyder SM, Teshome M, Barcenas CH, Miggins M, Adrada BE, Moseley T, Hwang RF, Hunt KK, Kuerer HM. PMID: 28423171; PMCID: PMC5547923.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    72. Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg. 2017 03; 265(3):574-580. Vila J, Teshome M, Tucker SL, Woodward WA, Chavez-MacGregor M, Hunt KK, Mittendorf EA. PMID: 27735826; PMCID: PMC11023020.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    73. Breast conserving surgery and locoregional control after neoadjuvant chemotherapy. Eur J Surg Oncol. 2017 May; 43(5):865-874. Teshome M, Kuerer HM. PMID: 28284519.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    74. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Ann Surg Oncol. 2017 Mar; 24(3):652-659. FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK, Babiera GV, Caudle AS, Black DM, Bedrosian I, Reyna C, Teshome M, Meric-Bernstam F, Hwang R. PMID: 27822630; PMCID: PMC5977973.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    75. Training of breast surgical oncologists. Chin Clin Oncol. 2016 Jun; 5(3):43. Teshome M, Kuerer HM. PMID: 27197510.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    76. Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis. Ann Surg Oncol. 2016 May; 23(5):1508-14. Teshome M, Wei C, Hunt KK, Thompson A, Rodriguez K, Mittendorf EA. PMID: 26893221.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    77. Neoadjuvant therapy in the treatment of breast cancer. Surg Oncol Clin N Am. 2014 Jul; 23(3):505-23. Teshome M, Hunt KK. PMID: 24882348; PMCID: PMC4044615.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    78. Early, intermediate, and late effects of a surgical skills "boot camp" on an objective structured assessment of technical skills: a randomized controlled study. J Am Coll Surg. 2010 Jun; 210(6):984-9. Parent RJ, Plerhoples TA, Long EE, Zimmer DM, Teshome M, Mohr CJ, Ly DP, Hernandez-Boussard T, Curet MJ, Dutta S. PMID: 20510808.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    79. A survey of demographics, motivations, and backgrounds among applicants to the integrated 0 + 5 vascular surgery residency. J Vasc Surg. 2010 Feb; 51(2):496-502; discussion 502-3. Lee JT, Teshome M, de Virgilio C, Ishaque B, Qiu M, Dalman RL. PMID: 20022205.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    80. The utility of endovascular simulation to improve technical performance and stimulate continued interest of preclinical medical students in vascular surgery. J Surg Educ. 2009 Nov-Dec; 66(6):367-73. Lee JT, Qiu M, Teshome M, Raghavan SS, Tedesco MM, Dalman RL. PMID: 20142137.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    81. Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol. 2008 Mar; 29(2):309-12. Onyekwere OC, Campbell A, Teshome M, Onyeagoro S, Sylvan C, Akintilo A, Hutchinson S, Ensing G, Gaskin P, Kato G, Rana S, Kwagyan J, Gordeuk V, Williams J, Castro O. PMID: 17680298.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    Mediget's Networks
    Concepts (213)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (5)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California